Tanya Turan to Angiotensin II Type 1 Receptor Blockers
This is a "connection" page, showing publications Tanya Turan has written about Angiotensin II Type 1 Receptor Blockers.
Connection Strength
0.041
-
The CREST-2 experience with the evolving challenges of COVID-19: A clinical trial in a pandemic. Neurology. 2020 07 07; 95(1):29-36.
Score: 0.041
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.